Harvard Bioscience, Inc.
HBIO
$0.762
-$0.0119-1.54%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -14.44% | -6.38% | 12.30% | -4.99% | 3.81% |
| Total Receivables | -14.36% | -26.13% | -13.69% | -3.63% | -0.27% |
| Inventory | 0.67% | -3.68% | -10.14% | -6.52% | -1.14% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -21.73% | -10.09% | 9.50% | 13.48% | -21.50% |
| Total Current Assets | -7.32% | -11.76% | -8.20% | -4.08% | -2.57% |
|
|
|||||
| Total Current Assets | -7.32% | -11.76% | -8.20% | -4.08% | -2.57% |
| Net Property, Plant & Equipment | 39.49% | 4.96% | -0.87% | -4.66% | -12.06% |
| Long-term Investments | 2.16% | -0.25% | 0.14% | 1.43% | 2.50% |
| Goodwill | 2.16% | -0.25% | 0.14% | 1.43% | 2.50% |
| Total Other Intangibles | -27.81% | -26.78% | -25.27% | -23.69% | -23.90% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -61.08% | -50.05% | -61.15% | -16.80% | -9.55% |
| Total Assets | -6.08% | -9.79% | -8.53% | -5.50% | -4.95% |
|
|
|||||
| Total Accounts Payable | -15.73% | 21.10% | 1.10% | -13.85% | 6.67% |
| Total Accrued Expenses | -31.27% | -36.61% | -0.37% | 14.48% | 10.18% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -15.41% | -10.61% | -3.59% | 22.35% | 15.58% |
| Total Finance Division Other Current Liabilities | 19.55% | 9.88% | 30.86% | 32.87% | 18.93% |
| Total Other Current Liabilities | 19.55% | 9.88% | 30.86% | 32.87% | 18.93% |
| Total Current Liabilities | -6.01% | -1.40% | 10.60% | 14.16% | 13.32% |
|
|
|||||
| Total Current Liabilities | -6.01% | -1.40% | 10.60% | 14.16% | 13.32% |
| Long-Term Debt | -2.26% | -16.34% | -23.20% | -28.62% | -24.20% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 51.79% | 1.29% | -7.72% | -9.24% | -20.24% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 27.82% | 38.41% | 42.63% | 41.10% | -3.00% |
| Total Liabilities | 0.72% | -8.66% | -9.67% | -12.10% | -12.77% |
|
|
|||||
| Common Stock & APIC | 1.31% | 1.44% | 1.44% | 1.48% | 2.04% |
| Retained Earnings | -9.90% | -7.49% | -6.17% | -2.40% | -2.32% |
| Treasury Stock & Other | 14.54% | -5.79% | -0.81% | 5.73% | 5.56% |
| Total Common Equity | -12.07% | -10.80% | -7.44% | 1.18% | 3.21% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -12.07% | -10.80% | -7.44% | 1.18% | 3.21% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -12.07% | -10.80% | -7.44% | 1.18% | 3.21% |
|
|
|||||
